Related Experiment Video
Updated: Jun 29, 2026

Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Vitamins and cardiovascular disease
1Department of Clinical Pharmacology, Faculty of Medicine, NHLI, ICL, St Mary's Hospital, London W2 1NY, UK. shohreh.honarbakhsh@ic.ac.uk
Insights
Vitamins show inconsistent results for cardiovascular disease (CVD) prevention. Targeted vitamin combinations may benefit specific populations like smokers and diabetics, but more research is needed.
Area of Science:
- Cardiovascular Disease Research
- Nutritional Science
- Oxidative Stress and Antioxidants
Background:
- Cardiovascular disease (CVD) is a leading global cause of mortality and morbidity.
- The role of vitamin supplementation in CVD prevention remains controversial, with inconsistent findings from observational studies and randomized controlled trials.
- Previous trials have not confirmed benefits for primary or secondary CVD prevention and some suggest potential harm in specific patient groups.
Purpose of the Study:
- To explore the inconsistent data regarding vitamin supplementation and cardiovascular disease.
- To investigate the potential benefits of specific vitamin combinations and targeted populations.
- To identify potential future roles for vitamins in managing CVD.
Main Methods:
- Review of existing observational studies and randomized controlled trials on vitamin supplementation and CVD.
- Analysis of the effects of single versus combination vitamin therapies.
- Examination of potential pro-oxidant effects of certain vitamins (e.g., beta-carotene) and antioxidant effects of others (e.g., vitamins E and C).
Main Results:
- Randomized controlled trials have largely failed to demonstrate a significant benefit of vitamin supplementation for CVD prevention.
- Some studies suggest beta-carotene may have pro-oxidant effects, potentially negating benefits of other vitamins in combination therapies.
- Combination therapy of vitamins E and C has shown anti-atherogenic effects, but clinical endpoint data remain inconsistent.
Conclusions:
- Current evidence does not support the general use of vitamin supplements for CVD prevention.
- Vitamins may be beneficial for specific subgroups, such as smokers, diabetics, and the elderly, who are prone to oxidative stress.
- Further research is needed to define optimal vitamin combinations and target populations for potential therapeutic benefits in CVD.
Abstract:
CVD is a major cause of mortality and morbidity in the Western world. In recent years its importance has expanded internationally and it is believed that by 2020 it will be the biggest cause of mortality in the world, emphasising the importance to prevent or minimise this increase. A beneficial role for vitamins in CVD has long been explored but the data are still inconsistent. While being supported by observational studies, randomised controlled trials have not yet supported a role for vitamins in primary or secondary prevention of CVD and have in some cases even indicated increased mortality in those with pre-existing late-stage atherosclerosis. The superiority of combination therapy over single supplementation has been suggested but this has not been confirmed in trials. Studies have indicated that beta-carotene mediates pro-oxidant effects and it has been suggested that its negative effects may diminish the beneficial effects mediated by the other vitamins in the supplementation cocktail. The trials that used a combination of vitamins that include beta-carotene have been disappointing. However, vitamin E and vitamin C have in combination shown long-term anti-atherogenic effects but their combined effect on clinical endpoints has been inconsistent. Studies also suggest that vitamins would be beneficial to individuals who are antioxidant-deficient or exposed to increased levels of oxidative stress, for example, smokers, diabetics and elderly patients, emphasising the importance of subgroup targeting. Through defining the right population group and the optimal vitamin combination we could potentially find a future role for vitamins in CVD.
Related Concept Videos
Vitamins
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
